nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2B6—Simvastatin—atherosclerosis	0.0722	0.102	CbGbCtD
Modafinil—CYP3A5—Rosuvastatin—atherosclerosis	0.0612	0.0863	CbGbCtD
Modafinil—CYP3A5—Simvastatin—atherosclerosis	0.0569	0.0803	CbGbCtD
Modafinil—CYP3A5—Pravastatin—atherosclerosis	0.0557	0.0785	CbGbCtD
Modafinil—CYP3A5—Lovastatin—atherosclerosis	0.0557	0.0785	CbGbCtD
Modafinil—CYP2C19—Rosuvastatin—atherosclerosis	0.0494	0.0696	CbGbCtD
Modafinil—CYP2C19—Simvastatin—atherosclerosis	0.0459	0.0647	CbGbCtD
Modafinil—CYP2C19—Lovastatin—atherosclerosis	0.0449	0.0633	CbGbCtD
Modafinil—CYP2C9—Rosuvastatin—atherosclerosis	0.041	0.0579	CbGbCtD
Modafinil—CYP2C9—Simvastatin—atherosclerosis	0.0382	0.0538	CbGbCtD
Modafinil—CYP2C9—Pravastatin—atherosclerosis	0.0373	0.0527	CbGbCtD
Modafinil—CYP2C9—Lovastatin—atherosclerosis	0.0373	0.0527	CbGbCtD
Modafinil—CYP3A4—Ezetimibe—atherosclerosis	0.0239	0.0337	CbGbCtD
Modafinil—CYP3A4—Rosuvastatin—atherosclerosis	0.0239	0.0337	CbGbCtD
Modafinil—CYP3A4—Simvastatin—atherosclerosis	0.0222	0.0313	CbGbCtD
Modafinil—CYP3A4—Lovastatin—atherosclerosis	0.0217	0.0306	CbGbCtD
Modafinil—CYP3A4—Pravastatin—atherosclerosis	0.0217	0.0306	CbGbCtD
Modafinil—Dimenhydrinate—HRH1—atherosclerosis	0.00116	0.151	CrCbGaD
Modafinil—Antazoline—HRH1—atherosclerosis	0.00103	0.135	CrCbGaD
Modafinil—Pheniramine—HRH1—atherosclerosis	0.00086	0.112	CrCbGaD
Modafinil—Diphenylpyraline—HRH1—atherosclerosis	0.000682	0.0888	CrCbGaD
Modafinil—Cyclizine—HRH1—atherosclerosis	0.000549	0.0715	CrCbGaD
Modafinil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000524	0.00241	CcSEcCtD
Modafinil—Muscle spasms—Ezetimibe—atherosclerosis	0.000523	0.00241	CcSEcCtD
Modafinil—Benzatropine—HRH1—atherosclerosis	0.000523	0.0681	CrCbGaD
Modafinil—Mental disorder—Simvastatin—atherosclerosis	0.000522	0.00241	CcSEcCtD
Modafinil—Tremor—Lovastatin—atherosclerosis	0.00052	0.00239	CcSEcCtD
Modafinil—Visual impairment—Pravastatin—atherosclerosis	0.000519	0.00239	CcSEcCtD
Modafinil—Ill-defined disorder—Lovastatin—atherosclerosis	0.000515	0.00237	CcSEcCtD
Modafinil—Flatulence—Simvastatin—atherosclerosis	0.000511	0.00235	CcSEcCtD
Modafinil—Erythema multiforme—Pravastatin—atherosclerosis	0.000509	0.00235	CcSEcCtD
Modafinil—Dysgeusia—Simvastatin—atherosclerosis	0.000508	0.00234	CcSEcCtD
Modafinil—Angioedema—Lovastatin—atherosclerosis	0.000507	0.00233	CcSEcCtD
Modafinil—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000505	0.00233	CcSEcCtD
Modafinil—Anaemia—Ezetimibe—atherosclerosis	0.000503	0.00232	CcSEcCtD
Modafinil—Malaise—Lovastatin—atherosclerosis	0.0005	0.0023	CcSEcCtD
Modafinil—Cardiac disorder—Pravastatin—atherosclerosis	0.0005	0.0023	CcSEcCtD
Modafinil—Muscle spasms—Simvastatin—atherosclerosis	0.000499	0.0023	CcSEcCtD
Modafinil—Vertigo—Lovastatin—atherosclerosis	0.000498	0.0023	CcSEcCtD
Modafinil—Angioedema—Ezetimibe—atherosclerosis	0.000497	0.00229	CcSEcCtD
Modafinil—Angiopathy—Niacin—atherosclerosis	0.000496	0.00229	CcSEcCtD
Modafinil—Chills—Niacin—atherosclerosis	0.000491	0.00226	CcSEcCtD
Modafinil—Malaise—Ezetimibe—atherosclerosis	0.000491	0.00226	CcSEcCtD
Modafinil—Arrhythmia—Niacin—atherosclerosis	0.000489	0.00225	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000487	0.00224	CcSEcCtD
Modafinil—Tremor—Simvastatin—atherosclerosis	0.000486	0.00224	CcSEcCtD
Modafinil—Chills—Pravastatin—atherosclerosis	0.000483	0.00223	CcSEcCtD
Modafinil—Insomnia—Rosuvastatin—atherosclerosis	0.000483	0.00223	CcSEcCtD
Modafinil—Ill-defined disorder—Simvastatin—atherosclerosis	0.000481	0.00222	CcSEcCtD
Modafinil—Arrhythmia—Pravastatin—atherosclerosis	0.000481	0.00222	CcSEcCtD
Modafinil—Palpitations—Ezetimibe—atherosclerosis	0.000481	0.00221	CcSEcCtD
Modafinil—Paraesthesia—Rosuvastatin—atherosclerosis	0.00048	0.00221	CcSEcCtD
Modafinil—Anaemia—Simvastatin—atherosclerosis	0.00048	0.00221	CcSEcCtD
Modafinil—Malnutrition—Niacin—atherosclerosis	0.000476	0.00219	CcSEcCtD
Modafinil—Cough—Ezetimibe—atherosclerosis	0.000475	0.00219	CcSEcCtD
Modafinil—Angioedema—Simvastatin—atherosclerosis	0.000474	0.00218	CcSEcCtD
Modafinil—Myalgia—Lovastatin—atherosclerosis	0.000472	0.00218	CcSEcCtD
Modafinil—Chest pain—Lovastatin—atherosclerosis	0.000472	0.00218	CcSEcCtD
Modafinil—Arthralgia—Lovastatin—atherosclerosis	0.000472	0.00218	CcSEcCtD
Modafinil—Anxiety—Lovastatin—atherosclerosis	0.000471	0.00217	CcSEcCtD
Modafinil—Dyspepsia—Rosuvastatin—atherosclerosis	0.00047	0.00217	CcSEcCtD
Modafinil—Hypertension—Ezetimibe—atherosclerosis	0.00047	0.00216	CcSEcCtD
Modafinil—Flatulence—Niacin—atherosclerosis	0.000469	0.00216	CcSEcCtD
Modafinil—Malaise—Simvastatin—atherosclerosis	0.000468	0.00216	CcSEcCtD
Modafinil—Tension—Niacin—atherosclerosis	0.000467	0.00215	CcSEcCtD
Modafinil—Discomfort—Lovastatin—atherosclerosis	0.000467	0.00215	CcSEcCtD
Modafinil—Vertigo—Simvastatin—atherosclerosis	0.000466	0.00215	CcSEcCtD
Modafinil—Arthralgia—Ezetimibe—atherosclerosis	0.000463	0.00213	CcSEcCtD
Modafinil—Chest pain—Ezetimibe—atherosclerosis	0.000463	0.00213	CcSEcCtD
Modafinil—Myalgia—Ezetimibe—atherosclerosis	0.000463	0.00213	CcSEcCtD
Modafinil—Nervousness—Niacin—atherosclerosis	0.000463	0.00213	CcSEcCtD
Modafinil—Flatulence—Pravastatin—atherosclerosis	0.000462	0.00213	CcSEcCtD
Modafinil—Dry mouth—Lovastatin—atherosclerosis	0.000462	0.00213	CcSEcCtD
Modafinil—Tension—Pravastatin—atherosclerosis	0.00046	0.00212	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00046	0.00212	CcSEcCtD
Modafinil—Dysgeusia—Pravastatin—atherosclerosis	0.000459	0.00212	CcSEcCtD
Modafinil—Muscle spasms—Niacin—atherosclerosis	0.000458	0.00211	CcSEcCtD
Modafinil—Discomfort—Ezetimibe—atherosclerosis	0.000458	0.00211	CcSEcCtD
Modafinil—Pain—Rosuvastatin—atherosclerosis	0.000457	0.0021	CcSEcCtD
Modafinil—Constipation—Rosuvastatin—atherosclerosis	0.000457	0.0021	CcSEcCtD
Modafinil—Confusional state—Lovastatin—atherosclerosis	0.000456	0.0021	CcSEcCtD
Modafinil—Nervousness—Pravastatin—atherosclerosis	0.000456	0.0021	CcSEcCtD
Modafinil—Dry mouth—Ezetimibe—atherosclerosis	0.000453	0.00209	CcSEcCtD
Modafinil—Anaphylactic shock—Lovastatin—atherosclerosis	0.000453	0.00209	CcSEcCtD
Modafinil—Muscle spasms—Pravastatin—atherosclerosis	0.000451	0.00208	CcSEcCtD
Modafinil—Infection—Lovastatin—atherosclerosis	0.00045	0.00207	CcSEcCtD
Modafinil—Confusional state—Ezetimibe—atherosclerosis	0.000448	0.00206	CcSEcCtD
Modafinil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000444	0.00205	CcSEcCtD
Modafinil—Arthralgia—Simvastatin—atherosclerosis	0.000442	0.00203	CcSEcCtD
Modafinil—Chest pain—Simvastatin—atherosclerosis	0.000442	0.00203	CcSEcCtD
Modafinil—Myalgia—Simvastatin—atherosclerosis	0.000442	0.00203	CcSEcCtD
Modafinil—Infection—Ezetimibe—atherosclerosis	0.000441	0.00203	CcSEcCtD
Modafinil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00044	0.00203	CcSEcCtD
Modafinil—Anxiety—Simvastatin—atherosclerosis	0.00044	0.00203	CcSEcCtD
Modafinil—Tremor—Pravastatin—atherosclerosis	0.000439	0.00202	CcSEcCtD
Modafinil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000437	0.00201	CcSEcCtD
Modafinil—Discomfort—Simvastatin—atherosclerosis	0.000436	0.00201	CcSEcCtD
Modafinil—Nervous system disorder—Ezetimibe—atherosclerosis	0.000435	0.00201	CcSEcCtD
Modafinil—Angioedema—Niacin—atherosclerosis	0.000435	0.00201	CcSEcCtD
Modafinil—Ill-defined disorder—Pravastatin—atherosclerosis	0.000435	0.002	CcSEcCtD
Modafinil—Anaemia—Pravastatin—atherosclerosis	0.000434	0.002	CcSEcCtD
Modafinil—Anorexia—Lovastatin—atherosclerosis	0.000431	0.00199	CcSEcCtD
Modafinil—Skin disorder—Ezetimibe—atherosclerosis	0.000431	0.00199	CcSEcCtD
Modafinil—Angioedema—Pravastatin—atherosclerosis	0.000429	0.00197	CcSEcCtD
Modafinil—Vertigo—Niacin—atherosclerosis	0.000428	0.00197	CcSEcCtD
Modafinil—Syncope—Niacin—atherosclerosis	0.000427	0.00197	CcSEcCtD
Modafinil—Confusional state—Simvastatin—atherosclerosis	0.000427	0.00197	CcSEcCtD
Modafinil—Urticaria—Rosuvastatin—atherosclerosis	0.000424	0.00195	CcSEcCtD
Modafinil—Anaphylactic shock—Simvastatin—atherosclerosis	0.000423	0.00195	CcSEcCtD
Modafinil—Oedema—Simvastatin—atherosclerosis	0.000423	0.00195	CcSEcCtD
Modafinil—Malaise—Pravastatin—atherosclerosis	0.000423	0.00195	CcSEcCtD
Modafinil—Abdominal pain—Rosuvastatin—atherosclerosis	0.000422	0.00195	CcSEcCtD
Modafinil—Vertigo—Pravastatin—atherosclerosis	0.000421	0.00194	CcSEcCtD
Modafinil—Palpitations—Niacin—atherosclerosis	0.000421	0.00194	CcSEcCtD
Modafinil—Infection—Simvastatin—atherosclerosis	0.000421	0.00194	CcSEcCtD
Modafinil—Loss of consciousness—Niacin—atherosclerosis	0.000419	0.00193	CcSEcCtD
Modafinil—Cough—Niacin—atherosclerosis	0.000416	0.00191	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000412	0.0019	CcSEcCtD
Modafinil—Insomnia—Lovastatin—atherosclerosis	0.000409	0.00189	CcSEcCtD
Modafinil—Cough—Pravastatin—atherosclerosis	0.000409	0.00189	CcSEcCtD
Modafinil—Paraesthesia—Lovastatin—atherosclerosis	0.000406	0.00187	CcSEcCtD
Modafinil—Myalgia—Niacin—atherosclerosis	0.000406	0.00187	CcSEcCtD
Modafinil—Arthralgia—Niacin—atherosclerosis	0.000406	0.00187	CcSEcCtD
Modafinil—Hypertension—Pravastatin—atherosclerosis	0.000405	0.00187	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000405	0.00186	CcSEcCtD
Modafinil—Anorexia—Simvastatin—atherosclerosis	0.000404	0.00186	CcSEcCtD
Modafinil—Dyspnoea—Lovastatin—atherosclerosis	0.000404	0.00186	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000403	0.00186	CcSEcCtD
Modafinil—Insomnia—Ezetimibe—atherosclerosis	0.000402	0.00185	CcSEcCtD
Modafinil—Myalgia—Pravastatin—atherosclerosis	0.000399	0.00184	CcSEcCtD
Modafinil—Arthralgia—Pravastatin—atherosclerosis	0.000399	0.00184	CcSEcCtD
Modafinil—Chest pain—Pravastatin—atherosclerosis	0.000399	0.00184	CcSEcCtD
Modafinil—Paraesthesia—Ezetimibe—atherosclerosis	0.000399	0.00184	CcSEcCtD
Modafinil—Dyspepsia—Lovastatin—atherosclerosis	0.000398	0.00184	CcSEcCtD
Modafinil—Anxiety—Pravastatin—atherosclerosis	0.000398	0.00183	CcSEcCtD
Modafinil—Dry mouth—Niacin—atherosclerosis	0.000397	0.00183	CcSEcCtD
Modafinil—Dyspnoea—Ezetimibe—atherosclerosis	0.000396	0.00182	CcSEcCtD
Modafinil—Discomfort—Pravastatin—atherosclerosis	0.000395	0.00182	CcSEcCtD
Modafinil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000394	0.00181	CcSEcCtD
Modafinil—Decreased appetite—Lovastatin—atherosclerosis	0.000394	0.00181	CcSEcCtD
Modafinil—Dyspepsia—Ezetimibe—atherosclerosis	0.000391	0.0018	CcSEcCtD
Modafinil—Fatigue—Lovastatin—atherosclerosis	0.00039	0.0018	CcSEcCtD
Modafinil—Anaphylactic shock—Niacin—atherosclerosis	0.000389	0.00179	CcSEcCtD
Modafinil—Oedema—Niacin—atherosclerosis	0.000389	0.00179	CcSEcCtD
Modafinil—Constipation—Lovastatin—atherosclerosis	0.000387	0.00178	CcSEcCtD
Modafinil—Pain—Lovastatin—atherosclerosis	0.000387	0.00178	CcSEcCtD
Modafinil—Confusional state—Pravastatin—atherosclerosis	0.000386	0.00178	CcSEcCtD
Modafinil—Decreased appetite—Ezetimibe—atherosclerosis	0.000386	0.00178	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000386	0.00178	CcSEcCtD
Modafinil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000383	0.00177	CcSEcCtD
Modafinil—Asthenia—Rosuvastatin—atherosclerosis	0.000383	0.00177	CcSEcCtD
Modafinil—Insomnia—Simvastatin—atherosclerosis	0.000383	0.00176	CcSEcCtD
Modafinil—Anaphylactic shock—Pravastatin—atherosclerosis	0.000383	0.00176	CcSEcCtD
Modafinil—Oedema—Pravastatin—atherosclerosis	0.000383	0.00176	CcSEcCtD
Modafinil—Fatigue—Ezetimibe—atherosclerosis	0.000383	0.00176	CcSEcCtD
Modafinil—Shock—Niacin—atherosclerosis	0.000383	0.00176	CcSEcCtD
Modafinil—Infection—Pravastatin—atherosclerosis	0.00038	0.00175	CcSEcCtD
Modafinil—Paraesthesia—Simvastatin—atherosclerosis	0.00038	0.00175	CcSEcCtD
Modafinil—Pain—Ezetimibe—atherosclerosis	0.00038	0.00175	CcSEcCtD
Modafinil—Constipation—Ezetimibe—atherosclerosis	0.00038	0.00175	CcSEcCtD
Modafinil—Tachycardia—Niacin—atherosclerosis	0.000379	0.00175	CcSEcCtD
Modafinil—Pruritus—Rosuvastatin—atherosclerosis	0.000378	0.00174	CcSEcCtD
Modafinil—Skin disorder—Niacin—atherosclerosis	0.000378	0.00174	CcSEcCtD
Modafinil—Dyspnoea—Simvastatin—atherosclerosis	0.000377	0.00174	CcSEcCtD
Modafinil—Hyperhidrosis—Niacin—atherosclerosis	0.000376	0.00173	CcSEcCtD
Modafinil—Cinnarizine—HRH1—atherosclerosis	0.000374	0.0488	CrCbGaD
Modafinil—Feeling abnormal—Lovastatin—atherosclerosis	0.000373	0.00172	CcSEcCtD
Modafinil—Dyspepsia—Simvastatin—atherosclerosis	0.000373	0.00172	CcSEcCtD
Modafinil—Anorexia—Niacin—atherosclerosis	0.000371	0.00171	CcSEcCtD
Modafinil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00037	0.00171	CcSEcCtD
Modafinil—Hyperhidrosis—Pravastatin—atherosclerosis	0.00037	0.0017	CcSEcCtD
Modafinil—Decreased appetite—Simvastatin—atherosclerosis	0.000368	0.0017	CcSEcCtD
Modafinil—Feeling abnormal—Ezetimibe—atherosclerosis	0.000366	0.00169	CcSEcCtD
Modafinil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000366	0.00168	CcSEcCtD
Modafinil—Diarrhoea—Rosuvastatin—atherosclerosis	0.000365	0.00168	CcSEcCtD
Modafinil—Fatigue—Simvastatin—atherosclerosis	0.000365	0.00168	CcSEcCtD
Modafinil—Anorexia—Pravastatin—atherosclerosis	0.000365	0.00168	CcSEcCtD
Modafinil—Hypotension—Niacin—atherosclerosis	0.000363	0.00167	CcSEcCtD
Modafinil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000363	0.00167	CcSEcCtD
Modafinil—Pain—Simvastatin—atherosclerosis	0.000362	0.00167	CcSEcCtD
Modafinil—Constipation—Simvastatin—atherosclerosis	0.000362	0.00167	CcSEcCtD
Modafinil—Urticaria—Lovastatin—atherosclerosis	0.00036	0.00166	CcSEcCtD
Modafinil—Body temperature increased—Lovastatin—atherosclerosis	0.000358	0.00165	CcSEcCtD
Modafinil—Abdominal pain—Lovastatin—atherosclerosis	0.000358	0.00165	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000354	0.00163	CcSEcCtD
Modafinil—Dizziness—Rosuvastatin—atherosclerosis	0.000353	0.00163	CcSEcCtD
Modafinil—Urticaria—Ezetimibe—atherosclerosis	0.000353	0.00162	CcSEcCtD
Modafinil—Insomnia—Niacin—atherosclerosis	0.000352	0.00162	CcSEcCtD
Modafinil—Body temperature increased—Ezetimibe—atherosclerosis	0.000351	0.00162	CcSEcCtD
Modafinil—Abdominal pain—Ezetimibe—atherosclerosis	0.000351	0.00162	CcSEcCtD
Modafinil—Paraesthesia—Niacin—atherosclerosis	0.000349	0.00161	CcSEcCtD
Modafinil—Feeling abnormal—Simvastatin—atherosclerosis	0.000349	0.00161	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000349	0.00161	CcSEcCtD
Modafinil—Dyspnoea—Niacin—atherosclerosis	0.000347	0.0016	CcSEcCtD
Modafinil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000346	0.00159	CcSEcCtD
Modafinil—Insomnia—Pravastatin—atherosclerosis	0.000346	0.00159	CcSEcCtD
Modafinil—Somnolence—Niacin—atherosclerosis	0.000346	0.00159	CcSEcCtD
Modafinil—Paraesthesia—Pravastatin—atherosclerosis	0.000344	0.00158	CcSEcCtD
Modafinil—Dyspepsia—Niacin—atherosclerosis	0.000342	0.00158	CcSEcCtD
Modafinil—Dyspnoea—Pravastatin—atherosclerosis	0.000341	0.00157	CcSEcCtD
Modafinil—Decreased appetite—Niacin—atherosclerosis	0.000338	0.00156	CcSEcCtD
Modafinil—Dyspepsia—Pravastatin—atherosclerosis	0.000337	0.00155	CcSEcCtD
Modafinil—Rash—Rosuvastatin—atherosclerosis	0.000337	0.00155	CcSEcCtD
Modafinil—Dermatitis—Rosuvastatin—atherosclerosis	0.000336	0.00155	CcSEcCtD
Modafinil—Urticaria—Simvastatin—atherosclerosis	0.000336	0.00155	CcSEcCtD
Modafinil—Gastrointestinal disorder—Niacin—atherosclerosis	0.000336	0.00155	CcSEcCtD
Modafinil—Abdominal pain—Simvastatin—atherosclerosis	0.000335	0.00154	CcSEcCtD
Modafinil—Body temperature increased—Simvastatin—atherosclerosis	0.000335	0.00154	CcSEcCtD
Modafinil—Headache—Rosuvastatin—atherosclerosis	0.000335	0.00154	CcSEcCtD
Modafinil—Hypersensitivity—Lovastatin—atherosclerosis	0.000334	0.00154	CcSEcCtD
Modafinil—Decreased appetite—Pravastatin—atherosclerosis	0.000333	0.00153	CcSEcCtD
Modafinil—Pain—Niacin—atherosclerosis	0.000332	0.00153	CcSEcCtD
Modafinil—Fatigue—Pravastatin—atherosclerosis	0.00033	0.00152	CcSEcCtD
Modafinil—Pain—Pravastatin—atherosclerosis	0.000327	0.00151	CcSEcCtD
Modafinil—Constipation—Pravastatin—atherosclerosis	0.000327	0.00151	CcSEcCtD
Modafinil—Hypersensitivity—Ezetimibe—atherosclerosis	0.000327	0.00151	CcSEcCtD
Modafinil—Asthenia—Lovastatin—atherosclerosis	0.000325	0.0015	CcSEcCtD
Modafinil—Ketoprofen—CXCL8—atherosclerosis	0.000324	0.0422	CrCbGaD
Modafinil—Pruritus—Lovastatin—atherosclerosis	0.00032	0.00148	CcSEcCtD
Modafinil—Asthenia—Ezetimibe—atherosclerosis	0.000319	0.00147	CcSEcCtD
Modafinil—Gastrointestinal pain—Niacin—atherosclerosis	0.000318	0.00146	CcSEcCtD
Modafinil—Nausea—Rosuvastatin—atherosclerosis	0.000317	0.00146	CcSEcCtD
Modafinil—Feeling abnormal—Pravastatin—atherosclerosis	0.000315	0.00145	CcSEcCtD
Modafinil—Pruritus—Ezetimibe—atherosclerosis	0.000314	0.00145	CcSEcCtD
Modafinil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000313	0.00144	CcSEcCtD
Modafinil—Hypersensitivity—Simvastatin—atherosclerosis	0.000312	0.00144	CcSEcCtD
Modafinil—Diarrhoea—Lovastatin—atherosclerosis	0.00031	0.00143	CcSEcCtD
Modafinil—Urticaria—Niacin—atherosclerosis	0.000309	0.00142	CcSEcCtD
Modafinil—Abdominal pain—Niacin—atherosclerosis	0.000307	0.00142	CcSEcCtD
Modafinil—Body temperature increased—Niacin—atherosclerosis	0.000307	0.00142	CcSEcCtD
Modafinil—Urticaria—Pravastatin—atherosclerosis	0.000304	0.0014	CcSEcCtD
Modafinil—Asthenia—Simvastatin—atherosclerosis	0.000304	0.0014	CcSEcCtD
Modafinil—Diarrhoea—Ezetimibe—atherosclerosis	0.000304	0.0014	CcSEcCtD
Modafinil—Abdominal pain—Pravastatin—atherosclerosis	0.000303	0.00139	CcSEcCtD
Modafinil—Body temperature increased—Pravastatin—atherosclerosis	0.000303	0.00139	CcSEcCtD
Modafinil—Pruritus—Simvastatin—atherosclerosis	0.0003	0.00138	CcSEcCtD
Modafinil—Dizziness—Lovastatin—atherosclerosis	0.000299	0.00138	CcSEcCtD
Modafinil—Dizziness—Ezetimibe—atherosclerosis	0.000294	0.00135	CcSEcCtD
Modafinil—Diarrhoea—Simvastatin—atherosclerosis	0.00029	0.00133	CcSEcCtD
Modafinil—Vomiting—Lovastatin—atherosclerosis	0.000288	0.00133	CcSEcCtD
Modafinil—Hypersensitivity—Niacin—atherosclerosis	0.000286	0.00132	CcSEcCtD
Modafinil—Rash—Lovastatin—atherosclerosis	0.000285	0.00131	CcSEcCtD
Modafinil—Dermatitis—Lovastatin—atherosclerosis	0.000285	0.00131	CcSEcCtD
Modafinil—Headache—Lovastatin—atherosclerosis	0.000284	0.00131	CcSEcCtD
Modafinil—Vomiting—Ezetimibe—atherosclerosis	0.000282	0.0013	CcSEcCtD
Modafinil—Hypersensitivity—Pravastatin—atherosclerosis	0.000282	0.0013	CcSEcCtD
Modafinil—Dizziness—Simvastatin—atherosclerosis	0.00028	0.00129	CcSEcCtD
Modafinil—Rash—Ezetimibe—atherosclerosis	0.00028	0.00129	CcSEcCtD
Modafinil—Dermatitis—Ezetimibe—atherosclerosis	0.00028	0.00129	CcSEcCtD
Modafinil—Asthenia—Niacin—atherosclerosis	0.000279	0.00128	CcSEcCtD
Modafinil—Headache—Ezetimibe—atherosclerosis	0.000278	0.00128	CcSEcCtD
Modafinil—Pruritus—Niacin—atherosclerosis	0.000275	0.00127	CcSEcCtD
Modafinil—Asthenia—Pravastatin—atherosclerosis	0.000275	0.00127	CcSEcCtD
Modafinil—Pruritus—Pravastatin—atherosclerosis	0.000271	0.00125	CcSEcCtD
Modafinil—Vomiting—Simvastatin—atherosclerosis	0.000269	0.00124	CcSEcCtD
Modafinil—Nausea—Lovastatin—atherosclerosis	0.000269	0.00124	CcSEcCtD
Modafinil—Diphenhydramine—HRH1—atherosclerosis	0.000269	0.035	CrCbGaD
Modafinil—Rash—Simvastatin—atherosclerosis	0.000267	0.00123	CcSEcCtD
Modafinil—Dermatitis—Simvastatin—atherosclerosis	0.000267	0.00123	CcSEcCtD
Modafinil—Diarrhoea—Niacin—atherosclerosis	0.000266	0.00123	CcSEcCtD
Modafinil—Headache—Simvastatin—atherosclerosis	0.000265	0.00122	CcSEcCtD
Modafinil—Nausea—Ezetimibe—atherosclerosis	0.000264	0.00121	CcSEcCtD
Modafinil—Diarrhoea—Pravastatin—atherosclerosis	0.000262	0.00121	CcSEcCtD
Modafinil—Dizziness—Niacin—atherosclerosis	0.000257	0.00118	CcSEcCtD
Modafinil—Orphenadrine—HRH1—atherosclerosis	0.000254	0.0331	CrCbGaD
Modafinil—Dizziness—Pravastatin—atherosclerosis	0.000253	0.00117	CcSEcCtD
Modafinil—Nausea—Simvastatin—atherosclerosis	0.000252	0.00116	CcSEcCtD
Modafinil—Vomiting—Niacin—atherosclerosis	0.000247	0.00114	CcSEcCtD
Modafinil—Rash—Niacin—atherosclerosis	0.000245	0.00113	CcSEcCtD
Modafinil—Dermatitis—Niacin—atherosclerosis	0.000245	0.00113	CcSEcCtD
Modafinil—Headache—Niacin—atherosclerosis	0.000244	0.00112	CcSEcCtD
Modafinil—Vomiting—Pravastatin—atherosclerosis	0.000243	0.00112	CcSEcCtD
Modafinil—Rash—Pravastatin—atherosclerosis	0.000241	0.00111	CcSEcCtD
Modafinil—Dermatitis—Pravastatin—atherosclerosis	0.000241	0.00111	CcSEcCtD
Modafinil—Headache—Pravastatin—atherosclerosis	0.00024	0.0011	CcSEcCtD
Modafinil—Nepafenac—PTGS2—atherosclerosis	0.000233	0.0304	CrCbGaD
Modafinil—Nausea—Niacin—atherosclerosis	0.000231	0.00106	CcSEcCtD
Modafinil—Nausea—Pravastatin—atherosclerosis	0.000227	0.00105	CcSEcCtD
Modafinil—Oxaprozin—PTGS2—atherosclerosis	0.000194	0.0252	CrCbGaD
Modafinil—Fosphenytoin—ALB—atherosclerosis	0.000179	0.0234	CrCbGaD
Modafinil—Fenoprofen—PTGS2—atherosclerosis	0.00016	0.0209	CrCbGaD
Modafinil—Fenoprofen—ALB—atherosclerosis	0.000143	0.0186	CrCbGaD
Modafinil—Phenylbutazone—PTGS2—atherosclerosis	0.000128	0.0167	CrCbGaD
Modafinil—Phenprocoumon—ALB—atherosclerosis	0.000123	0.016	CrCbGaD
Modafinil—Oxcarbazepine—ALB—atherosclerosis	0.00012	0.0156	CrCbGaD
Modafinil—Warfarin—ALB—atherosclerosis	0.000109	0.0142	CrCbGaD
Modafinil—Ketoprofen—PTGS2—atherosclerosis	9.45e-05	0.0123	CrCbGaD
Modafinil—Ketoprofen—ALB—atherosclerosis	8.42e-05	0.011	CrCbGaD
Modafinil—Phenytoin—ALB—atherosclerosis	7.92e-05	0.0103	CrCbGaD
Modafinil—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.66e-05	0.000251	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.66e-05	0.000251	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CG—atherosclerosis	1.66e-05	0.00025	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—BGN—atherosclerosis	1.65e-05	0.000249	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.64e-05	0.000247	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOA5—atherosclerosis	1.63e-05	0.000247	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.61e-05	0.000243	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.58e-05	0.000239	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.58e-05	0.000239	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KNG1—atherosclerosis	1.58e-05	0.000239	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AGTR1—atherosclerosis	1.57e-05	0.000238	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.57e-05	0.000237	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.55e-05	0.000235	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.54e-05	0.000233	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCL2—atherosclerosis	1.54e-05	0.000233	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.54e-05	0.000232	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.54e-05	0.000232	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.53e-05	0.000232	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PLG—atherosclerosis	1.53e-05	0.000232	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.53e-05	0.000231	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.52e-05	0.00023	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOA2—atherosclerosis	1.52e-05	0.00023	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.52e-05	0.00023	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.52e-05	0.00023	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.52e-05	0.000229	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.5e-05	0.000228	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.5e-05	0.000227	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.49e-05	0.000225	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.49e-05	0.000225	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.48e-05	0.000224	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—LIPC—atherosclerosis	1.48e-05	0.000224	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.48e-05	0.000224	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOC3—atherosclerosis	1.47e-05	0.000223	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—LDLR—atherosclerosis	1.46e-05	0.000221	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LPA—atherosclerosis	1.45e-05	0.00022	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SOCS3—atherosclerosis	1.45e-05	0.000219	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CETP—atherosclerosis	1.43e-05	0.000216	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BGN—atherosclerosis	1.41e-05	0.000213	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	1.4e-05	0.000212	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.4e-05	0.000212	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.4e-05	0.000211	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	1.4e-05	0.000211	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOA5—atherosclerosis	1.39e-05	0.000211	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—FABP4—atherosclerosis	1.39e-05	0.00021	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LCAT—atherosclerosis	1.39e-05	0.00021	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.37e-05	0.000207	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOA4—atherosclerosis	1.37e-05	0.000207	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.36e-05	0.000206	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOB—atherosclerosis	1.35e-05	0.000205	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.35e-05	0.000205	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.35e-05	0.000204	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—LIPC—atherosclerosis	1.35e-05	0.000204	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	1.34e-05	0.000203	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOC3—atherosclerosis	1.34e-05	0.000203	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.34e-05	0.000203	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.34e-05	0.000203	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—LDLR—atherosclerosis	1.33e-05	0.000202	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.33e-05	0.000202	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	1.33e-05	0.000202	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.33e-05	0.000201	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	1.32e-05	0.0002	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.31e-05	0.000199	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.31e-05	0.000198	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.31e-05	0.000198	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CETP—atherosclerosis	1.3e-05	0.000197	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.3e-05	0.000196	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LPL—atherosclerosis	1.29e-05	0.000196	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.29e-05	0.000195	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.28e-05	0.000193	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	1.26e-05	0.00019	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOB—atherosclerosis	1.25e-05	0.00019	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.25e-05	0.000189	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.24e-05	0.000188	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOB—atherosclerosis	1.23e-05	0.000185	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	1.22e-05	0.000185	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	1.22e-05	0.000184	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTM1—atherosclerosis	1.22e-05	0.000184	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.22e-05	0.000184	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.2e-05	0.000181	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—LPL—atherosclerosis	1.2e-05	0.000181	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.19e-05	0.00018	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.18e-05	0.000178	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.18e-05	0.000178	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOA2—atherosclerosis	1.18e-05	0.000178	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.18e-05	0.000178	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.18e-05	0.000178	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—LPL—atherosclerosis	1.17e-05	0.000177	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GPX1—atherosclerosis	1.17e-05	0.000177	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.17e-05	0.000176	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.16e-05	0.000176	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.16e-05	0.000176	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.16e-05	0.000175	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LIPC—atherosclerosis	1.15e-05	0.000175	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.15e-05	0.000174	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOC3—atherosclerosis	1.15e-05	0.000174	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GPX1—atherosclerosis	1.14e-05	0.000173	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LDLR—atherosclerosis	1.14e-05	0.000172	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CD36—atherosclerosis	1.14e-05	0.000172	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	1.13e-05	0.000171	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LPA—atherosclerosis	1.12e-05	0.00017	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CETP—atherosclerosis	1.11e-05	0.000168	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CD36—atherosclerosis	1.11e-05	0.000168	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AGT—atherosclerosis	1.11e-05	0.000167	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BGN—atherosclerosis	1.09e-05	0.000164	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LEP—atherosclerosis	1.08e-05	0.000164	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOE—atherosclerosis	1.08e-05	0.000164	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—atherosclerosis	1.08e-05	0.000163	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOA5—atherosclerosis	1.08e-05	0.000163	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	1.07e-05	0.000162	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	1.07e-05	0.000162	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.07e-05	0.000161	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.06e-05	0.000161	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARA—atherosclerosis	1.06e-05	0.00016	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—atherosclerosis	1.05e-05	0.000159	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.05e-05	0.000159	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.04e-05	0.000157	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.04e-05	0.000157	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	1.03e-05	0.000156	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARA—atherosclerosis	1.03e-05	0.000156	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AGT—atherosclerosis	1.02e-05	0.000155	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—F2—atherosclerosis	1.02e-05	0.000155	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.01e-05	0.000152	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOE—atherosclerosis	1e-05	0.000152	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AGT—atherosclerosis	1e-05	0.000151	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALOX5—atherosclerosis	1e-05	0.000151	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAV1—atherosclerosis	9.94e-06	0.00015	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOA1—atherosclerosis	9.92e-06	0.00015	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMOX1—atherosclerosis	9.89e-06	0.000149	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOE—atherosclerosis	9.8e-06	0.000148	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	9.78e-06	0.000148	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAV1—atherosclerosis	9.71e-06	0.000147	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOA1—atherosclerosis	9.69e-06	0.000147	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOB—atherosclerosis	9.47e-06	0.000143	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	9.37e-06	0.000142	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—INS—atherosclerosis	9.26e-06	0.00014	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—atherosclerosis	9.21e-06	0.000139	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	9.11e-06	0.000138	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.09e-06	0.000137	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—atherosclerosis	9.05e-06	0.000137	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—LPL—atherosclerosis	9.04e-06	0.000137	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMOX1—atherosclerosis	9.02e-06	0.000136	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCA1—atherosclerosis	8.98e-06	0.000136	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.97e-06	0.000136	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	8.96e-06	0.000135	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LIPC—atherosclerosis	8.91e-06	0.000135	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOC3—atherosclerosis	8.86e-06	0.000134	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—atherosclerosis	8.85e-06	0.000134	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPX1—atherosclerosis	8.82e-06	0.000133	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LDLR—atherosclerosis	8.8e-06	0.000133	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARG—atherosclerosis	8.74e-06	0.000132	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOB—atherosclerosis	8.64e-06	0.000131	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CETP—atherosclerosis	8.6e-06	0.00013	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CD36—atherosclerosis	8.59e-06	0.00013	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—INS—atherosclerosis	8.57e-06	0.00013	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARG—atherosclerosis	8.54e-06	0.000129	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	8.51e-06	0.000129	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—atherosclerosis	8.4e-06	0.000127	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—INS—atherosclerosis	8.38e-06	0.000127	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—LPL—atherosclerosis	8.25e-06	0.000125	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.23e-06	0.000124	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—atherosclerosis	8.14e-06	0.000123	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	8.12e-06	0.000123	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPX1—atherosclerosis	8.04e-06	0.000122	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARA—atherosclerosis	7.99e-06	0.000121	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—atherosclerosis	7.86e-06	0.000119	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CD36—atherosclerosis	7.83e-06	0.000118	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.78e-06	0.000118	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AGT—atherosclerosis	7.74e-06	0.000117	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.7e-06	0.000116	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—atherosclerosis	7.68e-06	0.000116	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOE—atherosclerosis	7.58e-06	0.000115	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NOS3—atherosclerosis	7.51e-06	0.000114	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAV1—atherosclerosis	7.51e-06	0.000114	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOA1—atherosclerosis	7.49e-06	0.000113	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—atherosclerosis	7.42e-06	0.000112	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOB—atherosclerosis	7.38e-06	0.000112	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NOS3—atherosclerosis	7.35e-06	0.000111	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARA—atherosclerosis	7.28e-06	0.00011	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	7.2e-06	0.000109	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—atherosclerosis	7.18e-06	0.000109	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AGT—atherosclerosis	7.05e-06	0.000107	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LPL—atherosclerosis	7.05e-06	0.000107	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	6.96e-06	0.000105	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.93e-06	0.000105	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOE—atherosclerosis	6.91e-06	0.000105	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPX1—atherosclerosis	6.87e-06	0.000104	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—atherosclerosis	6.87e-06	0.000104	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	6.85e-06	0.000104	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAV1—atherosclerosis	6.85e-06	0.000104	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—atherosclerosis	6.84e-06	0.000103	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOA1—atherosclerosis	6.83e-06	0.000103	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—atherosclerosis	6.72e-06	0.000102	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CD36—atherosclerosis	6.69e-06	0.000101	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARG—atherosclerosis	6.6e-06	9.98e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	6.52e-06	9.85e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—INS—atherosclerosis	6.48e-06	9.79e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	6.45e-06	9.75e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—atherosclerosis	6.34e-06	9.59e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	6.34e-06	9.58e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	6.32e-06	9.56e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.24e-06	9.43e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARA—atherosclerosis	6.22e-06	9.41e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AGT—atherosclerosis	6.03e-06	9.11e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARG—atherosclerosis	6.02e-06	9.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.95e-06	8.99e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—atherosclerosis	5.94e-06	8.98e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOE—atherosclerosis	5.91e-06	8.93e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—INS—atherosclerosis	5.9e-06	8.93e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAV1—atherosclerosis	5.85e-06	8.85e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	5.85e-06	8.85e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOA1—atherosclerosis	5.84e-06	8.83e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	5.79e-06	8.76e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOB—atherosclerosis	5.7e-06	8.61e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NOS3—atherosclerosis	5.68e-06	8.59e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.54e-06	8.38e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	5.53e-06	8.37e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LPL—atherosclerosis	5.44e-06	8.22e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—atherosclerosis	5.41e-06	8.18e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	5.37e-06	8.12e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.33e-06	8.06e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPX1—atherosclerosis	5.31e-06	8.02e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.19e-06	7.85e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NOS3—atherosclerosis	5.18e-06	7.83e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CD36—atherosclerosis	5.17e-06	7.81e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARG—atherosclerosis	5.14e-06	7.78e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—INS—atherosclerosis	5.05e-06	7.63e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.9e-06	7.4e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARA—atherosclerosis	4.8e-06	7.26e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.74e-06	7.16e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AGT—atherosclerosis	4.65e-06	7.03e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—atherosclerosis	4.63e-06	6.99e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOE—atherosclerosis	4.56e-06	6.89e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAV1—atherosclerosis	4.52e-06	6.83e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOA1—atherosclerosis	4.51e-06	6.81e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NOS3—atherosclerosis	4.42e-06	6.69e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.11e-06	6.22e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.05e-06	6.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—atherosclerosis	4.05e-06	6.12e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARG—atherosclerosis	3.97e-06	6e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—INS—atherosclerosis	3.89e-06	5.89e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	3.73e-06	5.64e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—atherosclerosis	3.57e-06	5.4e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—atherosclerosis	3.45e-06	5.22e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NOS3—atherosclerosis	3.41e-06	5.16e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—atherosclerosis	3.38e-06	5.11e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.12e-06	4.72e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—atherosclerosis	2.61e-06	3.95e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—atherosclerosis	2.38e-06	3.6e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—atherosclerosis	2.03e-06	3.08e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—atherosclerosis	1.57e-06	2.37e-05	CbGpPWpGaD
